参考文献/References:
[1] 张选明,王春霞,叶学锋.慢性肾小管-间质性肾炎发病机制的研究进展[J].现代中西医结合杂志,2007,16(7):1008-1010.
[2] Farris AB,Colvin RB.Renal interstitial fibrosis: mechanisms and evaluation[J].Current Opinion in Nephrology and Hypertension,2012,21(3): 289-300.
[3] Zeisberg M,Neilson EG.Mechanisms of tubulointerstitial fibrosis[J].Journal of the American Society of Nephrology:JASN,2010,21(11): 1819-1834.
[4] 徐 薇,于小勇,毛加荣,等.慢性肾小管间质疾病的病理改变临床特点与鉴别诊断[J].中国中西医结合肾病杂志,2018,19(7):606-607.
[5] 朱青青,李雪玲,钟逸斐.肾间质纤维化中西医治疗进展[J].中医学报,2019,34(1):54-58.
[6] 方东行,何立群,郑贤国.中医药治疗慢性间质性肾炎研究概况[J].中医学报,2015,30(9):1357-1359.
[7] 袁杭海,何立群.童少伯治疗慢性肾小管间质损伤临床经验[J].山东中医杂志,2016,35(12):1056-1058.
[8] 金一顺,严晓华,蓝健姿,等.系膜增生性肾小球肾炎肾小管间质损伤和中医辨证分型相关性分析[J].福建中医药,2012,43(2):3.
[9] Ostendorf T,Eitner F,Floege J.The PDGF family in renal fibrosis[J].Pediatr Nephrol,2012,27(7): 1041-1050.
[10] Mack M,Yanagiya M.Origin of myofibroblasts and cellular events triggering fibrosis[J].Kidney International,2015,87(2): 297-307.
[11] Buhl EM,Djudjaj S,Babickova J,et al.The role of PDGF-D in healthy and fibrotic kidneys[J].Kidney International,2016,89(4): 848-861.
[12] Kok HM,Falke LL,Goldschmeding R,et al.Targeting CTGF,EGF and PDGF pathways to prevent progression of kidney disease[J].Nature Reviews Nephrology,2014,10(12): 700-711.
[13] 张红梅,王献华,孙树勋.MMP-9、TIMP-1在阿霉素肾病大鼠肾小管间质病变中的表达[J].陕西医学杂志,2004,33(6):507-510.
[14] 程小红,于小勇,毛加荣.IgA肾病的病理改变与中医微观辨证[J].中国中西医结合肾病杂志,2014,15(2):185-186.
[15] 刘尚建,王耀献,李媛媛,等.“肾络微型癥瘕”理论初探[J].中国中医基础医学杂志,2009,15(9):649-650.
[16] 王耀献,刘尚建,付天昊,等.肾络微型癥瘕探微[J].中医杂志,2006,47(4):247-249.
[17] 史 健,杨洪涛,胡 锐,等.肾复康Ⅱ号抗肾间质纤维化及对人肾上皮小管细胞转分化的作用[J].陕西中医,2014,35(1):103-105.
[18] 毛加荣,徐 薇,刘建红,等.益肾散结法对UUO大鼠肾脏间质纤维化的影响[J].陕西中医,2018,39(2):146-149.
[19] 程小红,邢 斌,刘建红,等.益肾散结法对大鼠肾脏间质纤维化组织TGF-β1和PAI-1的影响[J].陕西中医,2018,39(2):143-145.
[20] 程小红,张晓凤,毛加荣,等.益肾散结复方对单侧输尿管结扎和5/6肾切除模型大鼠肾脏病理改变及肾功能的影响[J].陕西中医药大学学报,2018,41(1):93-96.